Revenue Growth and Strong Cash Flow
Novanta achieved $233 million in revenue for Q1 2025, representing 2% organic growth and 1% reported growth. The company also generated a robust $32 million in operating cash flows, maintaining a streak of strong cash flow conversion.
Successful Product Launches
The company confirmed $50 million of incremental new product revenue for 2025, driven by launches in surgical robotics, minimally invasive surgery applications, and other advanced technologies.
Strategic Acquisition
Novanta completed the acquisition of Keonn, an RFID solution provider, marking the first acquisition of 2025. This aligns with the strategy to expand into AI-enhanced software integrated with proprietary hardware.
Strong Performance in Medical Markets
Advanced Surgery business saw high single-digit growth due to strong patient procedure growth and hospital spending.
Innovative Technology Development
Novanta is making progress in markets like warehouse automation and precision robotics, with strong design win activity and new product sales growing in double digits.